Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PBK_M2101 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating PBK_M2101 for intestinal and colonic diseases is ongoing, with no current status available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Diseases
• Digestive System Disease
• Gastrointestinal Disease
• Intestinal Disease

Drugs mentioned

• PBK_M2101

Snippet

Sponsor: Pharmbio Korea Co., Ltd. | Conditions: Intestinal Disease, Colonic Diseases | Phase 3 | Status: UNKNOWN